Cargando…
MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways
Hepatocellular carcinoma (HCC) is the second leading cause of cancer related-death. As a major common regulator of numerous cancer-driving pathways and a unique therapeutic target, the prolyl isomerase Pin1 is overexpressed in a majority of HCCs, whereas the mechanism underlying Pin1 overexpression...
Autores principales: | Yan, Xingxue, Zhu, Zhendong, Xu, Shenmin, Yang, Li-nan, Liao, Xin-Hua, Zheng, Min, Yang, Dayun, Wang, Jichuang, Chen, Dongmei, Wang, Long, Liu, Xiaolong, Liu, Jingfeng, Chen, Ruey-Hwa, Zhen Zhou, Xiao, Ping Lu, Kun, Liu, Hekun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382892/ https://www.ncbi.nlm.nih.gov/pubmed/28383568 http://dx.doi.org/10.1038/srep45915 |
Ejemplares similares
-
Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma
por: Zheng, Min, et al.
Publicado: (2017) -
Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis
por: Chen, Linying, et al.
Publicado: (2019) -
The role of peptidyl-prolyl isomerase Pin1 in neuronal signaling in epilepsy
por: Chen, Yuwen, et al.
Publicado: (2022) -
Post-translational Modifications of the Peptidyl-Prolyl Isomerase Pin1
por: Chen, Dongmei, et al.
Publicado: (2020) -
Peptidyl-Prolyl Cis/Trans Isomerase Pin1 and Alzheimer’s Disease
por: Wang, Long, et al.
Publicado: (2020)